Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

498 SIMVASTATIN
(2003): Andreou ER+, Can J Clin Pharmacol 10(4), 172 (with
danazol)
(2003): Chiffoleau A+, Therapie 58(2), 168 (with verapamil and
cyclosporine)
(2003): de Denus S+, Am J Health Syst Pharm 60(17), 1791 (with
amiodarone)
(2003): Gumprecht J+, Med Sci Monit 9(9), CS89 (with
cyclosporine)
(2003): Pinilla Moraza J+, Rev Clin Esp 203(12), 615
(2003): Shaukat A+, Ann Pharmacother 37(7), 1032 (with
fluconazole)
(2003): Skrabal MZ+, Am J Health Syst Pharm 60(6), 578
(2003): Skrabal MZ+, South Med J 96(10), 1034 (with
nefazodone)
(2003): Wratchford P+, Am J Health Syst Pharm 60(7), 698
(2003): Yuen SL+, Med J Aust 179(3), 172 (with fusidic acid)
(2002): Cheng CH+, Am J Health Syst Pharm 59(8), 728
(2002): Hare CB+, Clin Infect Dis 35(10), e111 (with nelfinavir)
(2002): Rhodes CA+, Clin Nucl Med 27(11), 793
(2002): Thompson M+, Am J Psychiatry 159(9), 1607 (with
nefazodone)
(2001): Borrego FJ+, Nefrologia 21(3), 309
(2001): Federman DG+, South Med J 94(10), 1023 (with
gemfibrozil)
(2001): Kanathur N+, Tenn Med 94(9), 339 (with diltiazem)
(2001): Lee AJ, Ann Pharmacother 35(1), 26 (with clarithromycin)
(2001): Peces R+, Nephron 89(1), 117 (with diltiazem)
(2001): Reed BR, Denver, CO (from internet) (observation)
(2001): Stirling CM+, NephrolDialTransplant16(4), 873
(2000): Al Shohaib, Am J Nephrol 20(3), 212
(2000): Davidson MH, Curr Atheroscler Rep 2(1), 14
(2000): Kusus M+, Am J Med Sci 320(6), 394 (with cyclosporine,
digoxin and verapamil)
(2000): Oldemeyer JB+, Cardiology 94(2), 127 (with gemfibrozil)
(2000): Weise WJ+, Am J Med 108(4), 351
(1999): Bottorff M, Atherosclerosis 147(Suppl 1), S23
(1999): Corsini A+, Pharmacol Ther 84, 413 (with either
cyclosporine, mibefradil or nefazodone)
(1999): Gilad R+, Clin Neuropharmacol 22(5), 295 (with
ketoconazole)
(1999): Mogyorosi A+, J Intern Med 246(6), 599 (with warfarin)
(1997): Jacobson RH+, JAMA 277(4), 296 (with nefazodone)
(1997): Tal A+, South Med J 1997 May; 90(5), 546 (with
gemfibrozil)
(1996): Ballantyne CM+, Am J Cardiol 78(5), 532
(1996): van Puijenbroek EP+, J Intern Med 240(6), 403 (with
gemfibrozil)
(1995): Farmer JA+, Baillieres Clin Endocrinol Metab 9(4), 825
(1995): Garnett WR, Am J Health Syst Pharm 52(15), 1639 (with
either cyclosporine, erythromycin, gemfibrozil or niacin)
(1995): Meier C+, Schweiz Med Wochenschr 125(27), 1342 (with
cyclosporine)
(1992): Blaison G+, Rev Med Interne 13(1), 61 (with
cyclosporine)
(1992): Dromer C+, Rev Rhum Mal Osteoartic 59(4), 281
Tendinopathy/Tendon rupture
(2001): Chazerain P+, Joint Bone Spine 68(5), 430
*Note: Vytorin is a combination of ezetimibe and simvastatin
SINCALIDE
Trade name: Kinevac (Bracco)
Indications: Diagnostic aid for: gall bladder function, pancreatic
function, accelerating transit of barium meal
Category: Diagnostic aid; Hormone; Polypeptide
Half-life: 6 hours
Clinically important, potentially hazardous interactions
with: N/A
Reactions
Skin
Allergic reactions (sic) (